Palatin Technologies, Inc.
Melanocortin-1 Receptor-Specific Peptides for Cytokine Storm and Inflammation Therapy

Last updated:

Abstract:

Methods preventing, ameliorating or treating cytokine storm or inflammatory disease, indications, conditions and syndromes by administration of a therapeutically effective amount of a melanocortin-1 receptor-specific cyclic peptide or pharmaceutically acceptable salt thereof.

Status:
Application
Type:

Utility

Filling date:

13 Jul 2020

Issue date:

29 Oct 2020